Live feed
Filing
SC 13D/A
SC 13D/A0001193125-21-170910·Oyster Point Pharma, Inc.
Schedule 13D ownership disclosure
OYSTER POINT PHARMA INC
Security class unavailable · CUSIP: 69242L106
Event date: 2021-05-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-170910
- Form type
- SC 13D/A
- Filer
- Oyster Point Pharma, Inc.
- CIK
- CIK 1720725
- Filed
- May 24, 2021
- Reporting period
- May 12, 2021
- Description
- Schedule 13D beneficial ownership